HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jeffrey A Lieberman Selected Research
Jeffrey A Lieberman Research Topics
Disease
194
Schizophrenia (Dementia Praecox)
04/2024 - 02/2002
62
Psychotic Disorders (Schizoaffective Disorder)
07/2023 - 02/2002
45
Weight Gain
01/2023 - 02/2002
26
Tardive Dyskinesia
04/2024 - 08/2004
8
Psychomotor Agitation (Akathisia)
10/2019 - 08/2003
7
Obesity
01/2015 - 08/2004
6
Dyskinesias (Dyskinesia)
10/2020 - 11/2005
6
Cognitive Dysfunction
01/2020 - 01/2004
6
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 12/2005
6
Treatment-Resistant Schizophrenia
01/2019 - 10/2002
6
Body Weight (Weight, Body)
01/2018 - 01/2005
6
Alzheimer Disease (Alzheimer's Disease)
12/2010 - 10/2006
5
Movement Disorders (Movement Disorder)
01/2021 - 05/2009
5
Bipolar Disorder (Manic Depressive Psychosis)
05/2010 - 01/2004
5
Substance-Related Disorders (Drug Abuse)
03/2008 - 02/2004
4
Chronic Disease (Chronic Diseases)
07/2023 - 10/2009
4
Inflammation (Inflammations)
01/2019 - 12/2009
4
Mood Disorders (Mood Disorder)
01/2016 - 03/2003
4
Weight Loss (Weight Reduction)
09/2013 - 09/2005
4
Parkinsonian Disorders (Parkinsonism)
02/2010 - 08/2003
3
Agranulocytosis (Granulocytopenia)
01/2019 - 04/2006
3
Neurodegenerative Diseases (Neurodegenerative Disease)
10/2010 - 01/2004
3
Hyperglycemia
07/2009 - 09/2002
2
Atrophy
01/2020 - 04/2013
2
Sleep Initiation and Maintenance Disorders (Insomnia)
10/2019 - 07/2007
2
Insulin Resistance
01/2018 - 01/2005
2
Disease Progression
01/2017 - 05/2009
2
Drug-Related Side Effects and Adverse Reactions
09/2014 - 02/2010
2
Overweight
09/2013 - 07/2009
2
Eosinophilia
11/2011 - 04/2006
2
Hallucinations (Hallucination)
01/2011 - 10/2005
2
Neurobehavioral Manifestations
10/2009 - 07/2009
2
Coronary Disease (Coronary Heart Disease)
10/2008 - 12/2005
2
Hypertension (High Blood Pressure)
09/2006 - 12/2005
2
Hyperlipidemias (Hyperlipidemia)
09/2006 - 08/2004
2
Myocarditis (Carditis)
02/2006 - 08/2004
Drug/Important Bio-Agent (IBA)
151
Antipsychotic Agents (Antipsychotics)
IBA
01/2023 - 02/2002
58
Olanzapine (Zyprexa)
FDA Link
01/2018 - 02/2002
45
Clozapine (Clozaril)
FDA Link
Generic
01/2019 - 02/2002
35
Risperidone (Risperdal Consta)
FDA Link
Generic
10/2015 - 02/2002
22
Haloperidol (Haldol)
FDA Link
Generic
01/2013 - 02/2002
16
Quetiapine Fumarate (Seroquel)
FDA Link
05/2013 - 04/2006
14
Glutamic Acid (Glutamate)
FDA Link
07/2023 - 02/2003
12
Glucose (Dextrose)
FDA Link
Generic
01/2023 - 02/2003
12
Dopamine (Intropin)
FDA Link
Generic
01/2021 - 01/2004
10
ziprasidone (Geodon)
FDA Link
06/2012 - 09/2002
9
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2011
7
Proteins (Proteins, Gene)
FDA Link
11/2018 - 01/2004
7
Perphenazine (Trilafon)
FDA Link
Generic
01/2011 - 09/2005
6
Triglycerides (Triacylglycerol)
IBA
01/2023 - 01/2005
5
Insulin (Novolin)
FDA Link
01/2023 - 01/2005
5
Lipids
IBA
01/2018 - 01/2005
5
Prolactin
IBA
01/2011 - 01/2004
4
HDL Cholesterol
IBA
01/2023 - 12/2005
4
Molindone (Molindone Hydrochloride)
FDA Link
05/2012 - 08/2007
4
Neurosteroids
IBA
07/2009 - 06/2004
4
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
07/2009 - 08/2004
4
Cholesterol
IBA
11/2008 - 02/2003
3
gamma-Aminobutyric Acid (GABA)
IBA
01/2021 - 10/2009
3
Dopamine D2 Receptors (Dopamine D2 Receptor)
IBA
01/2021 - 05/2010
3
Enzymes
IBA
10/2020 - 11/2005
3
Serotonin (5 Hydroxytryptamine)
IBA
01/2020 - 02/2003
3
Protons (Proton)
IBA
01/2020 - 11/2005
3
N-Methylaspartate (NMDA)
IBA
01/2019 - 11/2006
3
Chlorpromazine (Thorazine)
FDA Link
01/2019 - 05/2003
3
Amphetamine (Amfetamine)
FDA Link
Generic
04/2015 - 12/2004
3
Brain-Derived Neurotrophic Factor (BDNF)
IBA
01/2015 - 05/2009
3
Peptides (Polypeptides)
IBA
02/2013 - 02/2004
3
Aripiprazole (Abilify)
FDA Link
06/2012 - 01/2004
3
Pregnenolone
IBA
07/2009 - 06/2006
3
Pregnanolone (Allopregnanolone)
IBA
12/2006 - 06/2004
2
Illicit Drugs (Recreational Drugs)
IBA
02/2021 - 03/2008
2
Cholinergic Receptors
IBA
01/2021 - 01/2020
2
Cholinergic Agents (Cholinergics)
IBA
01/2021 - 01/2019
2
Ketamine
FDA Link
Generic
10/2020 - 04/2013
2
Cytochrome P-450 CYP2D6 (CYP2D6)
IBA
10/2020 - 08/2012
2
lumateperone
IBA
01/2020 - 01/2016
2
Leptin
IBA
01/2020 - 01/2005
2
HLA-B Antigens (HLA-B)
IBA
01/2019 - 09/2014
2
HLA-DQB1 antigen (HLA DQB1)
IBA
01/2019 - 09/2014
2
Hormones (Hormone)
IBA
01/2019 - 01/2018
2
Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
IBA
01/2019 - 05/2013
2
Neuregulin-1 (Neuregulin 1)
IBA
01/2019 - 10/2008
2
Interleukin-6 (Interleukin 6)
IBA
01/2018 - 01/2015
2
Saline Solution
IBA
01/2018 - 01/2015
2
5-HT3 Serotonin Receptors (5 HT3 Receptor)
IBA
01/2016 - 04/2010
2
dihydrexidine
IBA
01/2016 - 01/2015
2
Catechol O-Methyltransferase (Methyltransferase, Catechol)
IBA
01/2016 - 10/2002
2
N-acetylaspartate (N-acetyl aspartate)
IBA
06/2013 - 11/2005
2
Oxytocin (Pitocin)
FDA Link
Generic
09/2011 - 07/2010
2
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
IBA
08/2010 - 06/2010
2
Antioxidants
IBA
12/2009 - 11/2005
2
Dehydroepiandrosterone (DHEA)
IBA
08/2008 - 06/2006
2
Cocaine (Cocaine HCl)
IBA
08/2006 - 02/2004
Therapy/Procedure
10
Therapeutics
01/2019 - 01/2005
5
Drug Therapy (Chemotherapy)
02/2017 - 02/2006
4
Duration of Therapy
01/2018 - 12/2005
2
Secondary Prevention
01/2021 - 01/2019
2
Aftercare (After-Treatment)
03/2008 - 10/2002
2
Time-to-Treatment
10/2005 - 01/2004